Sustainability & Climate

A new polyurethane foam service offers a faster, less disruptive, and more durable solution for South Carolina's common problem of sinking driveways and patios.

The Virginia-based startup landed a major funding round to automate liquid biopsy sample prep, aiming to make cancer detection faster and more reliable.

A biotech firm says it has grown functional human sperm in a lab and created embryos, a huge leap that could change millions of lives and spark ethical debate.

With a new strategic investor and a star executive on its board, Apreo Health is poised to advance its breakthrough BREATHE Airway Scaffold for severe emphysema.

A $25M payment from partner Chiesi catapults Protalix to a profitable quarter, funding a promising new gout therapy and a broader rare disease strategy.

Tired of flight delays and fragile supply chains? New MIT research reveals how companies can be both hyper-efficient and incredibly resilient.

A new report finds a "U-shaped" recovery where the richest and poorest schools improve, but the middle lags. A pre-pandemic "learning recession" persists.

Arco Vara sells a 25% stake in its Botanica Lozen project, handing management to a local partner to tap into Sofia's booming real estate market.

The uranium giant posts a net profit after its major acquisition, but a significant cash outflow has investors weighing long-term growth against short-term risks.

Amid Texas's growing water crisis, a new $3.7M contract for a high-efficiency water treatment plant highlights a critical move toward industrial self-reliance.

HireQuest's persistent $105M cash offer for TrueBlue's on-demand arm puts the staffing giant at a crossroads, fueling speculation of a sector shake-up.

A new study reveals Efsubaglutide Alfa not only controls diabetes but may also improve the body's own insulin-producing cells, heralding a new era.

As top execs head to the Morgan Stanley Luxury Conference, investors eye ELC's plans for global growth, profit recovery, and navigating a new era of beauty.

Disconnected tech systems create 'invisible leakage' in psychiatric practices, fueling burnout. A new approach aims to unify the operational chaos.

With a new CEO, a half-billion-dollar war chest, and a novel drug pipeline, Damora Therapeutics is making an aggressive play to redefine blood cancer treatment.

As BranchOut Food preps its Q1 earnings call, investors watch to see if its patented tech and retail wins can deliver on the path to profitability.

After two rejections and a dramatic financial restructuring, Atara Biotherapeutics has a clear path to resubmit its key cancer therapy to the FDA.

With cash to last into 2027, Bolt Biotherapeutics focuses all hope on its lead cancer drug, BDC-4182, ahead of crucial Q3 clinical data.

AWE 2026 honors XR legends, unveils groundbreaking art and research, and champions a future where spatial AI empowers, not replaces, humanity.

Kansas City is making history by welcoming four-legged fans to the FIFA Fan Festival, blending global soccer excitement with a major pet adoption initiative.